Award to avkare, LLC for montelukast HCL chewable tablets base year with four one year options. Base year effective 8/9/2021 - 8/8/2022.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79721D0036
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$5,717,484.30
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Montelukast HCL Chewable Tablets, a leukotriene receptor antagonist commonly used in the treatment of asthma and allergic rhinitis. The contract, valued at $5.72 million with an ultimate completion date of August 8, 2026, was awarded on August 9, 2021, following a pre-solicitation opportunity posted on February 17, 2021. The base year performance period runs from August 9, 2021, through August 8, 2022, with four one-year renewal options available. This procurement was conducted on an unrestricted, competitive basis without small business set-aside designations, enabling Avkare to compete directly against other qualified pharmaceutical suppliers in the federal marketplace.

The contract establishes a blanket purchasing agreement through which the Department of Veterans Affairs and potentially other federal healthcare agencies may issue delivery orders for Montelukast HCL Chewable Tablets to meet operational pharmaceutical needs across the federal healthcare system. As a critical component of Avkare's broader portfolio of pharmaceutical supply contracts with federal agencies, this indefinite delivery vehicle leverages the company's established capacity as a generic pharmaceutical distributor serving the Department of Veterans Affairs, Department of Defense, Indian Health Service, Bureau of Prisons, and related federal healthcare organizations. The contract includes a subcontracting plan requirement, with an update to the plan covering the period from January 1, 2026, through December 31, 2026, ensuring compliance with federal subcontracting requirements throughout the contract performance period.

Transactions

Action Obligated Date
Add Subcontract Plan P00013 · Update contract 36E79721D0036 subcontracting plan from 01/01/2026 - 12/31/2026. $0
Exercise an Option P00012 · Exercise option year four for 36E79721D0036 (montelukast chewable tablets) with no price changes effective 08/09/2025 - 08/08/2026. $0
Add Subcontract Plan P00011 · Update contract 36E79721D0036 subcontracting plan from 01/01/2025 - 12/31/2025. $0
Exercise an Option P00010 · Exercise option year three for 36E79721D0036 (montelukast chewable tablets) with no price changes effective 08/09/2024 - 08/08/2025. $0
Supplemental Agreement for work within scope P00009 · Update to cost recovery fee (CRF) and submission of quarterly sales reports $0
Add Subcontract Plan P00008 · Update contract 36E79721D0036 subcontracting plan from 01/01/2024 - 12/31/2024. $0
Exercise an Option P00007 · Exercise option year two for 36E79721D0036 (montelukast chewable tablets) with no price changes effective 8/9/2023 - 8/8/2024. $0
Other Administrative Action P00006 · Incorporate of drug supply chain security act (DSCSA) language into contract. $0
Add Subcontract Plan P00005 · Incorporate 2023 small business subcontracting plan into contract. $0
Exercise an Option P00004 · Exercise option year one for 36E79721D0036 (montelukast chewable tablets) with no price changes effective 8/9/2022 - 8/8/2023. $0
Add Subcontract Plan P00003 · Incorporate 2022 small business subcontracting plan. $0
Other Administrative Action P00002 · Update to contractor admin and sales pocs $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36E79721D0036?

36E79721D0036 was awarded to Avkare LLC by National Acquisition Center (Headquarters) on August 9, 2021.

How much is contract 36E79721D0036 worth?

36E79721D0036's own ceiling is $5,717,484.

Who can order from contract 36E79721D0036?

36E79721D0036 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36E79721D0036 competed?

The extent of competition for 36E79721D0036 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV